Puja Natesan, MD
Family Medicine · Hazelwood, MONPI 1306264932
Payments from drug & device makers
Across 121 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$317
- AstraZeneca$289
- AbbVie$285
- GSK$245
- Pfizer$226
- Lilly USA, LLC$172
- plus $457 from 12 others
What the payments were for
- Food & beverage$1,95998%
- Education$322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $317 |
| AstraZeneca | 16 | $289 |
| AbbVie | 15 | $285 |
| GSK | 12 | $245 |
| Pfizer | 21 | $226 |
| Lilly USA, LLC | 11 | $172 |
| Amgen | 6 | $101 |
| Exact Sciences | 5 | $82 |
| Novartis | 2 | $48 |
| Cranial Technologies, Inc | 4 | $43 |
| Abbott | 2 | $38 |
| Bayer | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Optinose US, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Ardelyx, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
How this compares
$1,991 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 87 | $578 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $304 |
| Amlodipine Besylate | 71 | $289 |
| Famotidine | 13 | $276 |
| Pantoprazole Sodium | 27 | $255 |
| Losartan Potassium | 43 | $254 |
| Escitalopram Oxalate | 21 | $248 |
| Fluticasone Propionate | 21 | $244 |
| Omeprazole | 15 | $243 |
| Levothyroxine Sodium | 31 | $224 |
| Trazodone Hcl | 20 | $218 |
| Tamsulosin Hcl | 15 | $184 |
| Rosuvastatin Calcium | 20 | $141 |
| Gabapentin | 13 | $140 |
| Lisinopril | 28 | $129 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hazelwood
- Artan MarkollariHazelwood$155K
- Delores DotsonHazelwood$100K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.